Deployment of drug-eluting stents for isolated proximal LAD disease is associated with lower major adverse cardiac events and no increase in stent thrombosis when compared with bare metal stents: A 5-year observational cohort study

Catheterization and Cardiovascular Interventions

Volumn 81, Issue 6, 2013, Pages

  Jones, Daniel A ^a,b   Rathod, Krishnaraj S ^a   Gallagher, Sean ^a   Weerackody, Roshan ^a   Knight, Charles J ^a,b   Rothman, Martin T ^a   Mathur, Anthony ^a,b   Jain, Ajay K ^a   Timmis, Adam D ^a   Wragg, Andrew ^a,b  

^a LONDON CHEST HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

bare metal stent (BMS); drug eluting stent (DES); left anterior descending (LAD); long term follow up; percutaneous coronary intervention (PCI)

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; PACLITAXEL; RAPAMYCIN; ZOTAROLIMUS;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; BLOOD CLOT LYSIS; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; INCIDENCE; INTRAVASCULAR ULTRASOUND; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; RETROSPECTIVE STUDY; REVASCULARIZATION; STENT THROMBOSIS;

AGED; CEREBROVASCULAR DISORDERS; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; CORONARY THROMBOSIS; DRUG THERAPY, COMBINATION; DRUG-ELUTING STENTS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; METALS; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; RISK FACTORS; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84876467043     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24513     Document Type: Article

References (18)

1. Lee CW, Tan C-H, Suh J, Lee S-W, Park D-W, Lee S-W, Kim Y-H, Hong M-K, Kim J-J, Park S-W, Park S-J,. Sirolimus-eluting stent implantation for treatment of proximal left anterior descending coronary artery lesions: Long-term outcome and predictors of adverse cardiac events. Catheterization Cardiovasc Interv 2007; 70: 368-373.
2. Sawhney N, Moses JW, Leon MB, Kuntz RE, Popma JJ, Bachinsky W, Bass T, DeMaio S, Fry E, Holmes DR Jr, Teirstein PS,. Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents. Circulation 2004; 110: 374-379.
3. National Institute for Health and Clinical Excellence (NICE). Ta152 coronary artery disease- drug-eluting stents: Guidance. 2008.
4. Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D, Guidelines ECfP, Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas PE, Widimsky P, Committee ECG, Alfieri O, Dunning J, Elia S, Kappetein P, Lockowandt U, Sarris G, Vouhe P, Reviewers D, von Segesser L, Agewall S, Aladashvili A, Alexopoulos D, Antunes MJ, Atalar E, Brutel de la Riviere A, Doganov A, Eha J, Fajadet J, Ferreira R, Garot J, Halcox J, Hasin Y, Janssens S, Kervinen K, Laufer G, Legrand V, Nashef SAM, Neumann F-J, Niemela K, Nihoyannopoulos P, Noc M, Piek JJ, Pirk J, Rozenman Y, Sabate M, Starc R, Thielmann M, Wheatley DJ, Windecker S, Zembala M,. Guidelines on myocardial revascularization. Eur Heart J 2010; 31: 2501-2555.
5. Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelb H, Menichelli M, Sabat M, Suttorp MJ, Baumgart D, Seyfarth M, Pfisterer ME, Schmig A,. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. New England J Med 2007; 356: 1030-1039.
6. Mauri L, Hsieh W-h, Massaro JM, Ho KKL, D'Agostino R, Cutlip DE,. Stent thrombosis in randomized clinical trials of drug-eluting stents. New England J Med 2007; 356: 1020-1029.
7. Ong ATL, Hoye A, Aoki J, van Mieghem CAG, Rodriguez Granillo GA, Sonnenschein K, Regar E, McFadden EP, Sianos G, van der Giessen WJ, de Jaegere PPT, de Feyter P, van Domburg RT, Serruys PW,. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 2005; 45: 947-953.
8. Alderman EL, Stadius M,. The angiographic definitions of the bypass angioplasty revascularization investigation. Coronary Artery Dis 1992; 3: 1189-207.
9. Ortiz-Perez JT, Meyers SN, Lee DC, Kansal P, Klocke FJ, et al. Angiographic estimates of myocardium at risk during acute myocardial infarction: Validation study using cardiac magnetic resonance imaging. Eur Heart J 2007; 28: 1750-1758.
10. Klein LW SR, Seelaus PA, Katz RI, Helfant RH,. Prognostic significance of severe narrowing of the proximal portion of the left anterior descending coronary artery. Am J Cardiol 1986; 1: 42-46.
11. American Heart Association Grading Committee coronary artery disease reporting system. Circulation 1975; 51: 31-33.
12. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es G-A, Gabriel Steg P, Morel M-a, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW, on behalf of the Academic Research Consortium. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007; 115: 2344-2351.
13. Dangas G, Ellis SG, Shlofmitz R, Katz S, Fish D, Martin S, Mehran R, Russell ME, Stone GW, TAXUS-IV Investigators. Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery. J Am Coll Cardiol 2005; 45: 1186-1192.
14. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice M-C, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran R, Leon MB,. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. New England J Med 2007; 356: 998-1008.
15. Cutlip DE, Baim DS, Ho KKL, Popma JJ, Lansky AJ, Cohen DJ, Carrozza JP Jr, Chauhan MS, Rodriguez O, Kuntz RE,. Stent thrombosis in the modern era: A pooled analysis of multicenter coronary stent clinical trials. Circulation 2001; 103: 1967-1971.
16. Eisenstein EL, Leon MB, Kandzari DE,. ENDEAVOR III Investigators. Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the Cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). J Am Coll Cardiol Intv 2009; 2: 1199-1207.
17. Kalesan B, Stefanini GG, Raber L, Schmutz M, Baumgartner S, Hitz S, Baldinger SH, Pilgrim T, Moschovitis A, Wenaweser P, Bullesfeld L, Khattab AA, Meier B, Juni P, Windecker S,. Long-term comparison of everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes. J Am College Cardiol: Cardiovasc Interv J Am Coll Cardiol Intv 2012; 5: 145-154.
18. Urban P, Gershlick AH, Guagliumi G, Guyon P, Lotan C, Schofer J, Seth A, Sousa JE, Wijns W, Berge C, Deme M, Stoll H-P, on behalf of the e-Cypher Investigators. Safety of coronary sirolimus-eluting stents in daily clinical practice: One-year follow-up of the e-cypher registry. Circulation 2006; 113: 1434-1441.